Epithelial integration in tissue-engineered oral mucosa using RGDTFI-presenting micropatterned collagen scaffolds

Le résumé fourni par la source

OBJECTIVE: To determine whether presentation of the integrin αvβ3/αvβ5-binding peptide motif RGDTFI on micropatterned collagen scaffolds improves epithelial coverage and stabilizes the epithelial-scaffold interface during fabrication of tissue-engineered oral mucosa (TEOM). METHODS: TEOMs were fabricated on micropatterned type I collagen scaffolds with or without RGDTFI presentation, pre-soaked with type IV collagen, laminin-511, or D-PBS. Epithelial coverage and interface integrity were evaluated by gross observation, histology, immunofluorescence analysis for laminin γ2 and integrins α6, β4, and β1, Ki-67 immunostaining, and ultrastructural analysis. Epithelial coverage was compared between the four scaffold conditions, and Ki-67 labeling indices were analyzed. RESULTS: RGDTFI presentation was associated with greater epithelial coverage and a more stable epithelial-scaffold interface on micropatterned collagen scaffolds, whereas non-modified scaffolds frequently had micro-gaps at the interface. TEOMs fabricated on RGDTFI-presenting scaffolds had stronger laminin γ2 deposition and integrin α6β4 expression in basal cells. Ultrastructural analysis revealed denser hemidesmosome-like electron-dense plaques, particularly in scaffolds pre-soaked with type IV collagen or laminin-511. Ki-67-positive basal cells were more frequent in rete ridge regions than in inter-ridge regions, and integrin β1 staining extended into suprabasal layers. CONCLUSIONS: Presentation of RGDTFI on micropatterned collagen scaffolds was associated with improved epithelial coverage and a more stable epithelial-scaffold interface in TEOMs, together with altered basement membrane-associated staining and integrin expression. These findings suggest that this strategy may assist in improving the stability and reproducibility of TEOMs in in vitro oral mucosa studies.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.